Clinical decision support tool for burn evaluation
Burn evaluation with Spectral AI's clinical decision support tool helps physicians treat burns with objective and immediate assessment of wound healing potential.

Spectral AI is an AI-powered medical diagnostics company that pairs AI with multispectral imaging for wound care.
spectral-ai.comCrawled Nov 10, 2026
Burn evaluation with Spectral AI's clinical decision support tool helps physicians treat burns with objective and immediate assessment of wound healing potential.
The page cites statistics on chronic wounds in the United States, including causes, healthcare costs, and reimbursement rules.
Scientific Evidence Stay up-to-date with the latest medical breakthroughs for Spectral AI.
Spectral AI recognizes the role of security researchers in promoting secure design practices.
Spectral AI develops wound care assessment and healing prediction technologies to improve patient outcomes.
Wound healing technologies provide an immediate wound healing assessment to clinicians with physiological information that is not visible to the human eye.
The page explains how AI imaging, including Spectral AI’s DeepView AI, advances burn and wound care diagnostics.
A blog series dedicated to the ideas, perspectives, and innovations that matter most in wound care.
The page outlines the stages of burn wound healing, factors influencing recovery, and key infection control measures.
Dive into the importance of accurate burns assessment, types of burns, key evaluation elements, initial injury management, and long-term care to improve patient outcomes.
The page describes key diagnostic tests for burns, including initial medical assessments and advanced imaging techniques.
Spectral AI recent media coverage. Media Coverage
News Coverage & Press Releases Stay up-to-date with the latest news, medical breakthroughs, and upcoming events.
DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView System,
DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company
DALLAS, April 30, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company
Spectral AI builds a team focused on advancing healthcare through creativity and ambition.
Ms. Johnson joined the Spectral AI team in October 2024. She oversees the global marketing at Spectral AI and has over 20 years’ experience in the
Ms. Bajko previously led commercialization and customer success at MediView XR, focusing on augmented reality visualization technologies for interventional radiology and surgery.
Ms. Prendergast advises Spectral AI on securities law, corporate governance, and strategic transactions, drawing on experience at Jones Day and A&O Shearman LLP.
Stan Micek leads research, development, and program management at Spectral AI, with experience in product commercialization and corporate transactions.
The page states Spectral AI’s mission to improve patient outcomes through immediate and objective wound healing assessments.
Request a Demo Learn more about the DeepView Wound Imaging System by speaking to a representative.
Spectral AI, a predictive analytics company, answers clinical questions through wound imaging, artificial intelligence algorithms, and wound assessment.
Spectral AI announces plans to release its third quarter 2026 financial results and hold a corresponding conference call for investors. The company, listed on Nasdaq under the ticker MDAI, provides updates on its financial performance and operational outlook through this scheduled event.
Spectral AI demonstrates its DeepView System at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly. The AI-powered platform supports emergency physicians with real-time clinical decision-making tools. The showcase highlights its integration into emergency care workflows, aiming to improve diagnostic accuracy and patient outcomes.
Spectral AI completes the first site initiation visit for its DeepView System clinical trial. The study aims to expand the product’s regulatory label to include treatment of burns on the head, hands, and feet. The DeepView System uses AI-driven imaging to assess burn severity and guide clinical decisions.
Spectral AI reports second-quarter 2026 financial results, highlighting a cash position of **$14.0 million**. The company provides AI-driven solutions for industrial asset performance monitoring. No revenue or earnings figures were disclosed in the announcement.
Spectral AI appoints Darcy Bajko as Chief Commercial Officer to oversee the global sales rollout of its FDA-cleared DeepView System, designed for burn treatment applications. The system integrates advanced imaging technology to aid clinical decision-making in burn care. Bajko brings commercial leadership experience to accelerate adoption of the medical device in hospitals and healthcare networks.
Spectral AI secures the Small Business Innovator Award at the first Texas Innovation Conference. The company, listed on Nasdaq under the ticker MDAI, highlights its recognition among innovators in the state.